NFKBIA and ovarian neoplasm: These encouraging results in a late-stage model indicate a potential future avenue for evaluating the synergistic effects of combining IκBα-MnNPs with chemotherapeutics to overcome the chemoresistance often associated with late-stage ovarian tumors.